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fungal cell membrane, which produces a disruption of its 
integrity and transport characteristics, resulting in the loss of 
intracellular potassium.4,6
The major side effects of amphotericin B are transient 
nephrotoxicity, hepatotoxicity and bone marrow suppres­
sion.7 Baley et al.4 reported that 7 of 10 VLBW infants with 
systemic candidiasis treated with a combination of amphoter­
icin B (1 mg/kg/day) and flucytosine (100 to 150 mg/kg/day) 
had severe nephrotoxicity manifested by oliguria or anuria 
and marked increases in blood urea nitrogen and creatinine. 
The deaths of 6 of the 7 infants were attributed in part to 
amphotericin B-induced nephrotoxicity. However, several of 
the infants had confounding factors such as multiple drug 
therapies and preexisting poor renal function. In contrast all
5 VLBW infants treated by Johnson et al.,2 with a smaller 
dosage of amphotericin B (0.5 to 1 mg/kg/day) and a similar 
dosage of flucytosine (50 to 150 mg/kg/day), tolerated therapy 
well and all survived. Since the report of Baley et al., the 
pharmacokinetics of amphotericin B in neonates has been 
studied and most of the treated infants have had more 
favorable outcomes.2,8
In this series little evidence of toxicity was observed 
despite some infants having abnormalities of renal, hepatic or 
hematopoietic function before receiving amphotericin B. The 
one infant with evidence of worsening renal function was 
probably affected by urinary tract obstruction. The transient 
occurrence of oliguria in sick VLBW infants is weak evidence 
of renal toxicity. We believe that the transient renal and 
hepatic abnormalities and thrombocytopenia are more likely 
related to the systemic infection or other preexisting prob­
lems rather than amphotericin B toxicity. Although it is not 
possible to exclude amphotericin B as a contributory factor in 
the deaths of four infants, overwhelming disseminated Can­
dida infection was the likely cause. Our experience supports 
the opinion of others who have reported that unlike adults 
and older children who experience fever, chills, nausea and 
vomiting, infants tolerate amphotericin B well.2,9' 10
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SERRATIA MARCESCENS PNEUMONIA, EMPYEMA
AND PNEUMATOCELE IN A PRETERM NEONATE
Neonatal pneumonia has been associated with many infec­
tious agents. Staphylococcus aureus is the most common 
cause of pneumonia associated with empyema and pneumato­
cele formation in the newborn.1 Neonatal pneumonia with 
empyema caused by Serratia marcescens has not to our 
knowledge been described in the English literature. We 
describe such a case in a preterm neonate and present a 
review of similar neonatal infections caused by Gram- 
negative aerobic bacilli.
Case report. The patient was a 755-g male neonate born 
at 26 weeks of gestation by precipitous vaginal delivery to a 
18-year-old primigrávida after an uncomplicated pregnancy. 
The initial course was complicated by hyaline membrane 
disease, bilateral grade III intraventricular hemorrhage, a 
persistent ductus arteriosus that was treated with indometh- 
acin and multiple blood transfusions for anemia. From Day of 
Life (DOL) 7 until DOL 15 the infant was extub ate d and 
reintubated for continuing respiratory problems, had blood, 
urine and tracheal aspirate cultures and received vancomycin 
and amikacin for 72 h. A 5-day weaning course of dexameth- 
asone (initial dose, 0.5 mg/kg/day) was started on DOL 10.
On DOL 15 the patient was reintubated for hypoxemia, 
bradycardia, hypotension and decreased urine output. Blood, 
tracheal aspirate and urine cultures were obtained and treat­
ment with vancomycin and amikacin was begun. A spinal tap 
was unsuccessful. A chest roentgenograph showed a large 
pneumatocele on the right. Twelve hours later a repeat chest 
roentgenograph revealed a tension pneumothorax on the 
right, and a thoracotomy tube was placed with no evidence of 
fluid at that time. The pneumothorax reaccumulated and 
serosanguinous fluid was noted in the chest tube on DOL 17. 
Two new chest tubes were inserted for drainage of the 
empyema. The Gram-stained pleural fluid showed many 
leukocytes and Gram-negative bacilli. Cefotaxime was added 
to the antibiotic regimen, and on DOL 20 a right thoracotomy 
with decortication was performed and the empyema was 
drained. Multiple ruptured pneumatoceles were discovered 
and sutured, and two new chest tubes were inserted.
Three blood cultures (DOL 17,19 and 21), tracheal aspirate 
(DOL 15) and preoperative (DOL 17) and operative (DOL 20) 
empyema fluid grew S. marcescens susceptible to all the 
aminoglycosides and to cefotaxime. The urine and a previous 
tracheal aspirate culture from DOL 10 were sterile. Blood
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TABLE 1. Characteristics of seven neonates with Gram-negative empyema and pneumatocele formation
Reference Age , (Days/Sex) Wt (g)
Underlying
Illness
Radiologic
Features Organism
Source Treatment Outcome
2 0/NA NA Prematurity NA Klebsiella pneumoniae, 
Enterobacter
Pleural fluid Antibiotics D
3 9/F 1000 Prematurity Bilateral P, Pc, 
Px and E
Klebsiella pneumoniae Blood Antibiotics and chest 
tube
S
4 2/M 4200 Infant of diabetic 
mother
Right P, Pc Escherichia coli Blood, CSF, stool, 
throat
Antibiotics S
4 2/NA 3500 None Right P, Pc Escherichia coli Blood, stool, 
throat, 
nasopharynx
Antibiotics S
4 2/M 2700 None Left P, Pc Escherichia coli Blood, urine, 
throat
Antibiotics S
5 0/M 3347 None Right P, Pc, E, Px Escherichia coli Pleural fluid Antibiotics and chest 
tube
S
This report 14/M 755 Prematurity Right P, Px, Pc, E Serratia marcescens Blood, pleural 
fluid
Antibiotics, chest 
tube, decortication
S
NA, not available; P, pneumonia; Pc, pneumatocoelc; Px, pneumothorax; E, empyema; CSF, cerebrospinal fluid; S, survived; D, died.
(DOL 23, 29), cerebrospinal fluid (DOL 29) and ventricular 
fluid (DOL 30) cultures were sterile. The infant was treated 
with cefotaxime and gentamicin and the other antibiotics 
were discontinued. The infant improved slowly, the chest 
tubes were removed on DOL 28 and the infant was extub ate d 
on DOL 39. Routine cultures failed to identify other infants in 
the neonatal intensive care unit that were colonized with S. 
marcescens. However, surveillance cultures were not done.
The chest roentgenograph continued to show a persistent 
right pneumatocele that resolved after 8 weeks. The total 
duration of antibiotics was 21 days post decortication. The 
infant is now 7 months old and has hypertonia, developmen­
tal delay and a ventriculoperitoneal shunt for hydrocephalus.
Review of literature. We found reports of seven neonates 
with Gram-negative empyema and pneumatocele formation 
with pneumonia, including our patient (Table l ).2"6 One 
neonate with Escherichia coli empyema was excluded because 
no other information was available.6 Four were full term 
neonates and three were preterm (age 0 to 14 days). Radio- 
graphically all had pneumatocele formation; four had associ­
ated empyema and three had pneumothorax as well. The 
etiologic agents were E. coli in four, Klebsiella pneumoniae in 
one, K. pneumoniae and Enterobacter cloacae in one and S. 
marcescens in our patient. All were treated with antibiotics 
and three of the four with empyema required thoracotomy 
tube drainage. One infant died. Only our patient had decor­
tication. The pneumatoceles persisted asymptomatically 
among these infants for 1 to 10 months. One patient had 
recurrence of pneumothorax at ages 42 and 73 days.3
Discussion. In neonates, including those born prema­
turely, empyema is uncommon and when described usually 
has been associated with Staphylococcus aureus,1,2,G~8 
Gram-negative organisms less commonly cause empyema or 
pneumatocele formation. 5. marcescens has not been de­
scribed as a cause of empyema, with or without pneumatocele 
formation, in neonates. However, it has been described as a 
cause of pneumonia, lung abscess and empyema in older 
children with underlying immunodeficiency.9 In adults S . 
marcescens pleural empyema is also uncommon.10
S. marcescens is a recognized pathogen in neonates and has 
been associated with neonatal intensive care unit out­
breaks.11”20 These outbreaks affect primarily preterm neo­
nates, and the clinical manifestations have included bactere­
mia, pneumonia, soft tissue infection, urinary tract infection 
and meningitis.11"20 Case fatality rates have been as high as 
69%.11-20 None of the neonates with pneumonia had empy­
ema or pneumatocele formation. In one outbreak two prema­
ture infants with S . marcescens septicemia had bilateral
pneumothoraces.18 It is difficult to say whether bilateral 
pneumothoraces were a result of the severe idiopathic respi­
ratory distress syndrome these infants had or occurred before 
the development of empyema given that both infants died.
Contributing factors for invasive disease caused by S. 
marcescens include exposure to contaminated instruments 
and fluids, peripheral intravenous catheters, use of steroids 
and broad spectrum antibiotics and prior colonization. Colo­
nization rates of 95% in uninfected infants and 10% in 
hospital staff may occur early in hospitalization during these 
outbreaks.19,20 In our case the infant had received steroids 
and antibiotics. There was no documentation that this neo­
nate was colonized with S . marcescens earlier than the 
tracheal aspirate culture on DOL 15.
The diagnosis of empyema is suspected on chest roentgeno­
graphs and confirmed by examination and culture of pleural 
fluid. The yield for a positive empyema culture is 50 to 66% in 
children after the newborn period.2,8 Treatment can be 
guided by results of Gram-stained smears of pleural fluid and 
when uncertain consist of antimicrobial agents active against 
Staphylococcus aureus and Gram-negative organisms. A tho­
racotomy tube with closed drainage is initially used to drain 
the empyema, hasten recovery and decrease complications.
a noninvasive proce­
dure, has been successful in older children but experience 
with this procedure in the newborn period is limited. Decor­
tication should be considered if there is evidence of loculated 
fluid or fluid too viscous to be adequately drained by thora­
cotomy tube.
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